Innovatiefonds MKB+ has made the first venture investment in Dutch biotech company Aeon Astron Europe.
The new equity will be used to support the company's expansion plans, including the addition of seven labs and a clean room, as well as an increase in the number of staff. The funding will also support...
Venture capital firms originally invested in the company in 2011 and 2014 respectively
Fund manager Quaestus exits its stake in the Croatian business after an eight-year holding period
Proposed deal for the aluminium profiles manufacturer comes just two years after Advent's acquisition
Deal marks first investment by small-cap buyout fund Crescendo, which held a €42m first close this year